Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 1, 2005

View Archived Issues

Combined statin and L-arginine treatment opens new possibilities for clinical research

XOS supplementation reported to improve the gastrointestinal microflora of obese patients

Sho-saiko-to selectively inhibits CD8+ cells

STELLAR 3 trial of Xyotax reaches required number of events

Orphan drug designation for Tocosol Paclitaxel for bladder cancer indication

Agreements to develop AP-23573 drug delivery stents

Tarvacin cleared to enter new phase I study

NIDA grant supports drug addiction therapy development at InfleXion

Orphan drug status for PTC-124 for Duchenne muscular dystrophy

Quadramet and docetaxel to be evaluated for cancer spread to bone

GSK and Transport sign agreement for iontophoretic delivery of aciclovir

Thiazolidinediones show promise in the treatment of diabetic vascular complications

Fast track status for Viprinex for ischemic stroke

Analgesic effects reported for AM-404 in a model of neuropathic pain

Enrollment completed in study of Durin-leuprolide implant for Alzheimer's

Provensis seeks to lift Varisolve clinical hold

Neuroprotective effects of ethyl pyruvate in a preclinical model of Parkinson's disease

Chiesi and Novartis sign agreement for Formoterol Modulite

Tanabe Seiyaku signs addendum to Remicade license agreement in Japan

Rigel claims agents for hepatitis C infection

Kowa scientists describe new compounds for diabetes and related complications

New MCHR antagonists for obesity and other uses reported by Banyu

Two series of cannabinoid receptor modulators disclosed by Japan Tobacco

Pharmacia identifies new protein kinase inhibitors

New DPP-IV inhibitors discovered at Syrrx

5HT-7 receptor modulators and their use in IBS claimed by Ajinomoto

Amgen launches Kepivance

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...